Nanomolar inhibitors of the transcription factor STAT5b with high selectivity over STAT5a
Src homology 2 (SH2) domains play a central role in signal transduction. Although many SH2 domains have been validated as drug targets, their structural similarity makes development of specific inhibitors difficult. The cancer-relevant transcription facto